Concepedia

Graziana Digiacomo

GD

Statistics

Publications

20

Citations

926

H-Index

17

Active since

2013

Affiliations

University of Parma(Current)

Istituto Nazionale per l'Assicurazione Contro gli Infortuni sul Lavoro

University of Florence

Fondazione Pisa

Istituti Ospitalieri di Cremona

Graziana Digiacomo is an author at University of Parma specializing in medicine, oncology, and molecular oncology.

Publications per year

2013–2024

20

Publications

20

Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells

Mara Bonelli, Graziana Digiacomo, Claudia Fumarola et al. · Neoplasia · 2017 · 105 citations · Full text

, , +17

The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells

Daniele Cretella, Andrea Ravelli, Claudia Fumarola et al. · Journal of Experimental & Clinical Cancer Research · 2018 · 105 citations · Full text

, , +16

Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines

Silvia La Monica, Daniele Cretella, Mara Bonelli et al. · Journal of Experimental & Clinical Cancer Research · 2017 · 89 citations · Full text

, , +16

Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells

Daniele Cretella, Claudia Fumarola, Mara Bonelli et al. · Scientific Reports · 2019 · 87 citations · Full text

, , +17

Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC

Silvia La Monica, Roberta Minari, Daniele Cretella et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 70 citations · Full text

, , +15

1–5 of 20